BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND HLA-A, P01892, 3105, ENSG00000206503, P16188, P30447, P13746, P04439 AND Treatment
16 results:

  • 1. Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial.
    D'Angelo SP; Araujo DM; Abdul Razak AR; Agulnik M; Attia S; Blay JY; Carrasco Garcia I; Charlson JA; Choy E; Demetri GD; Druta M; Forcade E; Ganjoo KN; Glod J; Keedy VL; Le Cesne A; Liebner DA; Moreno V; Pollack SM; Schuetze SM; Schwartz GK; Strauss SJ; Tap WD; Thistlethwaite F; Valverde Morales CM; Wagner MJ; Wilky BA; McAlpine C; Hudson L; Navenot JM; Wang T; Bai J; Rafail S; Wang R; Sun A; Fernandes L; Van Winkle E; Elefant E; Lunt C; Norry E; Williams D; Biswas S; Van Tine BA
    Lancet; 2024 Apr; 403(10435):1460-1471. PubMed ID: 38554725
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Safety and Efficacy of NY-ESO-1 Antigen-Specific T-Cell Receptor Gene-Transduced T Lymphocytes in Patients with Synovial Sarcoma: A Phase I/II Clinical Trial.
    Kawai A; Ishihara M; Nakamura T; Kitano S; Iwata S; Takada K; Emori M; Kato K; Endo M; Matsumoto Y; Kakunaga S; Sato E; Miyahara Y; Morino K; Tanaka S; Takahashi S; Matsuo F; Matsumine A; Kageyama S; Ueda T
    Clin Cancer Res; 2023 Dec; 29(24):5069-5078. PubMed ID: 37792433
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Immunotherapy resistance driven by loss of NY-ESO-1 expression in response to transgenic adoptive cellular therapy with PD-1 blockade.
    Frankiw L; Singh A; Peters C; Comin-Anduix B; Berent-Maoz B; Macabali M; Shammaie K; Quiros C; Kaplan-Lefko P; Baselga Carretero I; Ribas A; Nowicki TS
    J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37156551
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. T-cell receptor gene therapy targeting melanoma-associated antigen-A4 by silencing of endogenous TCR inhibits tumor growth in mice and human.
    Sun Q; Zhang X; Wang L; Gao X; Xiong Y; Liu L; Wei F; Yang L; Ren X
    Cell Death Dis; 2019 Jun; 10(7):475. PubMed ID: 31209257
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinicopathologic Features of a Series of Primary Renal CIC-rearranged sarcomas With Comprehensive Molecular Analysis.
    Mangray S; Kelly DR; LeGuellec S; Fridman E; Aggarwal S; Shago M; Matoso A; Madison R; Pramanik S; Zhong S; Li R; Lombardo KA; Cramer S; Pressey J; Ross JS; Corona RJ; Bratslavsky G; Argani P; Coindre JM; Somers GR; Ali SM; Yakirevich E
    Am J Surg Pathol; 2018 Oct; 42(10):1360-1369. PubMed ID: 29901569
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Human Leukocyte Antigen-A Allele Distribution in Nasopharyngeal Carcinoma Patients Showing Anti-Melanoma-Associated Antigen A or Synovial Sarcoma X-2 T Cell Response in Blood.
    Fan PW; Huang L; Chang XM; Feng YN; Yao X; Peng YC; Dong T; Wang RZ
    Chin Med J (Engl); 2018 Jun; 131(11):1289-1295. PubMed ID: 29786040
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response.
    Robbins PF; Kassim SH; Tran TL; Crystal JS; Morgan RA; Feldman SA; Yang JC; Dudley ME; Wunderlich JR; Sherry RM; Kammula US; Hughes MS; Restifo NP; Raffeld M; Lee CC; Li YF; El-Gamil M; Rosenberg SA
    Clin Cancer Res; 2015 Mar; 21(5):1019-27. PubMed ID: 25538264
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Specific targeting of a naturally presented osteosarcoma antigen, papillomavirus binding factor peptide, using an artificial monoclonal antibody.
    Tsukahara T; Emori M; Murata K; Hirano T; Muroi N; Kyono M; Toji S; Watanabe K; Torigoe T; Kochin V; Asanuma H; Matsumiya H; Yamashita K; Himi T; Ichimiya S; Wada T; Yamashita T; Hasegawa T; Sato N
    J Biol Chem; 2014 Aug; 289(32):22035-47. PubMed ID: 24962571
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Human leukocyte antigen distribution in German Caucasians with advanced Ewing's sarcoma.
    Thiel U; Wolf P; Wawer A; Blaeschke F; Grunewald TG; von Lüttichau IT; Klingebiel T; Bader P; Borkhardt A; Laws HJ; Handgretinger R; Lang P; Schlegel PG; Eyrich M; Gruhn B; Ehninger G; Koscielniak E; Klein C; Sykora KW; Holler E; Mauz-Körholz C; Woessmann W; Richter GH; Schmidt AH; Peters C; Dirksen U; Jürgens H; Bregni M; Burdach S
    Klin Padiatr; 2012 Oct; 224(6):353-8. PubMed ID: 22821288
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Soluble human leukocyte antigen-G serum levels in patients with acquired immune deficiency syndrome affected by different disease-defining conditions before and after antiretroviral treatment.
    Murdaca G; Contini P; Setti M; Cagnati P; Spanò F; Lantieri F; Puppo F
    Hum Immunol; 2011 Sep; 72(9):712-6. PubMed ID: 21663783
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Chemotherapeutic drugs may be used to enhance the killing efficacy of human tumor antigen peptide-specific CTLs.
    Correale P; Del Vecchio MT; La Placa M; Montagnani F; Di Genova G; Savellini GG; Terrosi C; Mannucci S; Giorgi G; Francini G; Cusi MG
    J Immunother; 2008; 31(2):132-47. PubMed ID: 18481383
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999.
    Brooks SE; Zhan M; Cote T; Baquet CR
    Gynecol Oncol; 2004 Apr; 93(1):204-8. PubMed ID: 15047237
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Identification of hla-a*0201-restricted CTL epitopes encoded by the tumor-specific MAGE-2 gene product.
    Visseren MJ; van der Burg SH; van der Voort EI; Brandt RM; Schrier PI; van der Bruggen P; Boon T; Melief CJ; Kast WM
    Int J Cancer; 1997 Sep; 73(1):125-30. PubMed ID: 9334819
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Allogeneic bone marrow transplantation for a patient with malignant histiocytosis].
    Zhai M; Hu L; Chen H
    Zhonghua Xue Ye Xue Za Zhi; 1997 Aug; 18(8):395-6. PubMed ID: 15625841
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Malignant bone and soft-tissue tumor and HLA.
    Wong AC
    Nihon Seikeigeka Gakkai Zasshi; 1985 Jul; 59(7):719-33. PubMed ID: 3864905
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Selective extraction by 1-butanol of surface glycoprotein antigens from human melanoma cells.
    Liao SK; Smith JW; Kwong PC
    Cancer Immunol Immunother; 1984; 17(2):95-9. PubMed ID: 6205747
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.